Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Zagonel

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Critical Reviews in Oncology/Hematology|August 14, 2001
Prevalence of functional disability among elderly patients with cancerD Serraino, L Fratino, V Zagonel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Common errors in conducting and reporting clinical trials in non-Hodgkin lymphomas and patients' ageU Tirelli, V Zagonel, S Monfardini
Critical Reviews in Oncology/Hematology|May 8, 1998
Multiple myelomaG B Zulian, R Babare, V Zagonel
Critical Reviews in Oncology/Hematology|May 8, 1998
LymphomasS Monfardini, V Zagonel, E M Noordijk
Critical Reviews in Oncology/Hematology|February 13, 2001
A 20-year experience on malignant lymphomas in patients aged 70 and older at a single instituteU Tirelli, A Carbone, S Monfardini, et al.
Blood|February 1, 1996
Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomasA Carbone, A Gloghini, V Zagonel, et al.
Leukemia & Lymphoma|July 31, 1998
Acute myeloid leukemia in the elderly: a critical review of therapeutic approaches and appraisal of results of therapyF Ferrara, S Mirto, V Zagonel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in ItalyD Serraino, V Zagonel, R Bordonaro, et al.
British Journal of Haematology|November 1, 1990
Expression of natural killer antigens in a subset of 'non-T, non-B lymphoma/leukaemia with histiocytic features'V Gattei, A Carbone, V Zagonel, et al.
Haematologica|March 1, 1987
Management of non-Hodgkin's lymphomas in the elderlyU Tirelli, V Zagonel, A Carbone, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Critical Reviews in Oncology/Hematology|August 14, 2001
Prevalence of functional disability among elderly patients with cancerD Serraino, L Fratino, V Zagonel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Common errors in conducting and reporting clinical trials in non-Hodgkin lymphomas and patients' ageU Tirelli, V Zagonel, S Monfardini
Critical Reviews in Oncology/Hematology|May 8, 1998
Multiple myelomaG B Zulian, R Babare, V Zagonel
Critical Reviews in Oncology/Hematology|May 8, 1998
LymphomasS Monfardini, V Zagonel, E M Noordijk
Critical Reviews in Oncology/Hematology|February 13, 2001
A 20-year experience on malignant lymphomas in patients aged 70 and older at a single instituteU Tirelli, A Carbone, S Monfardini, et al.
Blood|February 1, 1996
Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomasA Carbone, A Gloghini, V Zagonel, et al.
Leukemia & Lymphoma|July 31, 1998
Acute myeloid leukemia in the elderly: a critical review of therapeutic approaches and appraisal of results of therapyF Ferrara, S Mirto, V Zagonel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in ItalyD Serraino, V Zagonel, R Bordonaro, et al.
British Journal of Haematology|November 1, 1990
Expression of natural killer antigens in a subset of 'non-T, non-B lymphoma/leukaemia with histiocytic features'V Gattei, A Carbone, V Zagonel, et al.
Haematologica|March 1, 1987
Management of non-Hodgkin's lymphomas in the elderlyU Tirelli, V Zagonel, A Carbone, et al.
Pageof 16